◀ Back to PCNA
CDC25A — PCNA
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
-
STRING interaction:
CDC25A
—
PCNA
(interaction, mapped from kegg_pathways)
-
STRING interaction:
PCNA
—
CDC25A
(interaction, mapped from kegg_pathways)
Text-mined interactions from Literome
Blomberg et al., Mol Cell Biol 1999
:
In vitro,
Cdc25A dephosphorylates and
activates the
cyclin-Cdk complexes that are active during G ( 1 ) ... Overexpression of
Cdc25A in the inducible system, however,
leads to a premature activation of both cyclin E-Cdk2 and
cyclin A-Cdk2 complexes, while no effect of cyclin D-dependent kinases is observed
Sandhu et al., Oncogene 2000
:
Recombinant Cdc25A strongly reactivated cyclin E-cdk2 from senescent HMECs suggesting that reduction of
Cdc25A contributes to
cyclin E-cdk2 inhibition and G1 arrest at senescence ... In contrast, in the breast cancer derived MCF-7 line,
Cdc25A overexpression
increased both
cyclin E-cdk2 activity and the S phase fraction
Jaime et al., Hepatology 2002
:
In conclusion, premature translocation of
CDC25A to the nucleus might be
involved in the advanced induction of
cyclin E/CDK2 activity and DNA replication in cells from animals lacking p21 ( Cip1 )
Chow et al., Mol Biol Cell 2003
:
DNA damage during the spindle-assembly checkpoint degrades
CDC25A ,
inhibits cyclin-CDC2 complexes, and reverses cells to interphase
Ray et al., Mol Cancer Ther 2007
(Prostatic Neoplasms) :
Cdc25A dependent regulation of
cyclin dependent kinase 2 (Cdk2) and changes in association of p21 ( WAF1/CIP1 ) and hSpy1 with Cdk2 resulted in inhibition of Cdk2 associated kinase activity
Yao et al., Toxicology 2008
:
In the S-phase checkpoint induced by BaP the reduction of
Cdc25A contributes to
cyclin A inhibition
Solc et al., Dev Biol 2008
:
CDC25A/B/C are dual-specificity phosphatases and
activate cyclin dependent kinases (CDKs)
Pereg et al., Nat Cell Biol 2010
(Breast Neoplasms...) :
The dual specificity ( Tyr/Thr ) phosphatase
Cdc25A activates
cyclin dependent kinases (Cdks) to promote cell-cycle progression and has significant oncogenic potential